Influence of Ukrain on patients with surgically treated breast cancer. Part III. The immune system.
The present study was undertaken to evaluate the influence of Ukrain on immune parameters in ten patients with breast cancer, treated with the drug in the preoperative phase. The control group consisted of eight patients of similar age and advancement of the disease, who did not receive Ukrain before mastectomy. The data were compared with the parameters obtained in 15 healthy blood donors. It was found that treatment with Ukrain distinctly regulates cellular and, slightly, humoral immunity, non-specific immunity and also complement activity.
Fomin
K A
KA
Medical Institute, Grodno, Belarus.
Uglyanica
K N
KN
Nefyodov
L I
LI
Djurd
T I
TI
Nowicky
J W
JW
Brzosko
W J
WJ
Jankowski
A
A
D000328:Adult; D000470:Alkaloids / Q000627:therapeutic use*; D000917:Antibody Formation / Q000187:drug effects; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001600:Berberine Alkaloids; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology* / Q000601:surgery; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007070:Immunoglobulin A / Q000097:blood; D007074:Immunoglobulin G / Q000097:blood; D010617:Phenanthridines; D013601:T-Lymphocytes / Q000187:drug effects
D000470:Alkaloids; D000970:Antineoplastic Agents; D001600:Berberine Alkaloids; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D010617:Phenanthridines; C060921:ukrain